Evidence map›Paper›PMID 32405173›Full record

ArticleBioinformation2020

Linking gut microbiota with the human diseases.

Udaya Kumar Vandana, Naseema Hayat Barlaskar, Abu Barkat Md Gulzar, Islamul Hoque Laskar, Diwakar Kumar, Prosenjit Paul, Piyush Pandey, Pranab Behari Mazumder

Abstract read
In one paragraph

Article in Bioinformation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Udaya Kumar VandanaDepartment of Biotechnology, Assam University, Silchar, Assam, India.
Naseema Hayat BarlaskarDepartment of Biotechnology, Assam University, Silchar, Assam, India.
Abu Barkat Md GulzarDepartment of Biotechnology, Assam University, Silchar, Assam, India.
Islamul Hoque LaskarDepartment of Biotechnology, Assam University, Silchar, Assam, India.
Diwakar KumarDepartment of Microbiology, Assam University, Silchar, Assam, India.
Prosenjit PaulDepartment of Biotechnology, Assam University, Silchar, Assam, India.
Piyush PandeyDepartment of Microbiology, Assam University, Silchar, Assam, India.
Pranab Behari MazumderDepartment of Biotechnology, Assam University, Silchar, Assam, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human gut is rich in microbes. Therefore, it is of interest to document data to link known human diseases with the gut microbiota. Various factors like hormones, metabolites and dietary habitats are responsible for shaping the microbiota of the gut. Imbalance in the gut microbiota is responsible for the pathogenesis of various disease types including rheumatoid arthritis, different types of cancer, diabetes mellitus, obesity, and cardiovascular disease. We report a review of known data for the correction of dysbiosis (imbalance in microbe population) towards improved human health.

Indexed as

BacteriacancerdysbiosisGut microbiomeimmunoglobulinshort chain fatty acids

Identifiers

PMID32405173
PMCPMC7196170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.